Palexia Depot (Tapentadol Hydrochloride)

Palexia Depot is an opioid analgesic that acts on the central nervous system to relieve pain associated with several conditions.

• Chronic cancer‑related pain: provides long‑acting relief for patients with persistent tumor‑related pain.
• Severe neuropathic pain: helps reduce pain intensity in neuropathic syndromes unresponsive to other opioids.
• Post‑surgical pain after major orthopedic procedures: offers extended analgesia when oral opioids are insufficient.

• Tapentadol Hydrochloride binds to μ‑opioid receptors, producing analgesia through opioid agonism, while simultaneously inhibiting norepinephrine reuptake, which enhances descending inhibitory pain pathways. This dual mechanism yields effective pain control with a potentially lower incidence of typical opioid‑related side effects.

Tapentadol Hydrochloride may cause a range of adverse reactions, most of which are dose‑dependent and reversible upon discontinuation.

Common Side Effects

• Nausea: mild to moderate upset stomach often reported.
• Dizziness: transient light‑headedness, especially when standing quickly.
• Constipation: reduced bowel motility common with opioid therapy.
• Somnolence: feeling unusually sleepy or fatigued.
• Headache: mild to moderate cranial pain.
• Dry mouth: reduced salivation leading to a parched feeling.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing that may be life‑threatening.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Seizures: rare convulsive episodes, particularly in patients with a seizure history.
• Serotonin syndrome: risk when combined with serotonergic agents.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• adrenal ​

When using Palexia Depot, clinicians should assess individual risk factors and monitor patients regularly.

• Assess renal and hepatic function: adjust therapy if impairment is present.
• Evaluate for respiratory depression risk: especially in opioid‑naïve patients.
• Review medication history: avoid concurrent use with other central nervous system depressants.
• Counsel  
• Store at ambient: keep the 

• The safety profile ​  
• ---
• ---
• ---  
•   
• t  
• t 
• t \